<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>MicroRNAs (miRNAs) are small non-coding <z:chebi fb="40" ids="33697">RNAs</z:chebi> exhibiting critical functions as post-transcriptional regulators </plain></SENT>
<SENT sid="1" pm="."><plain>Due to the importance and extensive influence of miRNAs on genes, dysregulation of miRNAs has been associated with various types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, with more prominent being colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Increasing evidence suggests that miRNAs mediate the initiation and development of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and also act as potential biomarkers for both diagnosis and prognosis </plain></SENT>
<SENT sid="3" pm="."><plain>In this review, we summarize the recent advancement of miRNA research in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, in particular, the miRNAs which interact with critical pathways such as p53, NF-kappa B, beta-catenin pathways and also play a significant role in the regulation of EMT and maintenance of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cell </plain></SENT>
</text></document>